42 EWAP 2022年12月 䬨হ㻯◦ 性EI 很少见，清除后不会引起 视力变化。作者还表明，研究 并不支持先前提出的EI 风险因 素，如增强前时间间隔、㺨瓣工 ⳱、性别和年⼰。这是㋻今为 止最大的回顾性研究，分析了 LASIK 再掀瓣，并グ㗰了一种并 发㺄发生率低的特㗜手术技术。 作者提出了一个令人信服的论 点，即在初次治疗多年后，再掀 瓣将成为LASIK 增强术的首选方 法。EWAP 参考文㦇 1. Moshirfar M, et al. LASIK enhancement: clinical and surgical management. J Refract Surg. 2017;33:116–127. 2. Cagil N, et al. Effectiveness of laser-assisted subepithelial keratectomy to treat residual refractive errors after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:642–647. 3. Carones F, et al. Evaluation of photorefractive keratectomy retreatments after regressed myopic laser in situ keratomileusis. Ophthalmology. 2001;108:1732–1737. 4. de Rojas V, et al. Infectious keratitis in 18,651 laser surface ablation procedures. J Cataract Refract Surg. 2011;37:1822–1831. 5. Schallhorn SC, et al. Flap lift and photorefractive keratectomy enhancements after primary laser in situ keratomileusis using a wavefront-guided ablation profile: Refractive and visual outcomes. J Cataract Refract Surg. 2015;41:2501–2512. 6. Caster AI. Flap-lift LASIK 10 or more years after primary LASIK. J Refract Surg. 2018;34:604–609. 7. Davis EA, et al. Lasik enhancements: a comparison of lifting to recutting the flap. Ophthalmology. 2002;109:2308–2314. 8. Rubinfeld RS, et al. To lift or recut: changing trends in LASIK enhancement. J Cataract Refract Surg. 2003;29:2306–2317. 9. Vaddavalli PK, et al. Complications of femtosecond laser-assisted re-treatment for residual refractive errors after LASIK. J Refract Surg. 2013;29:577–580. 10. Domniz Y, et al. Recutting the cornea versus lifting the flap: comparison of two enhancement techniques following laser in situ keratomileusis. J Refract Surg. 2001;17:505–510. 11. Ali Del arrio JL, et al. Laser flap enhancement 5 to 9 years and 10 or more years after laser in situ keratomileusis: Safety and efficacy. J Cataract Refract Surg. 2019;45:1463–1469. 12. Santhiago MR, et al. Flap relift for retreatment after femtosecond laser-assisted LASIK. J Refract Surg. 2012;28:482–487. 13. Randleman JB, Shah RD. LASIK interface complications: etiology, management, and outcomes. J Refract Surg. 2012;28:575–586. 14. Wang MY, Maloney RK. Epithelial ingrowth after laser in situ keratomileusis. Am J Ophthalmol. 2000;129:746–751. 15. Letko E, et al. Influence of original flap creation method on incidence of epithelial ingrowth after LASIK retreatment. J Refract Surg. 2009;25:1039–1041. 16. Caster AI, et al. Incidence of epithelial ingrowth in primary and retreatment laser in situ keratomileusis. J Cataract Refract Surg. 2010;36:97–101. 17. Henry CR, et al. Epithelial ingrowth after LASIK: clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift. J Refract Surg. 2012;28:488–492. 18. Ting DSJ, et al. Epithelial ingrowth following laser in situ keratomileusis (LASIK): prevalence, risk factors, management and visual outcomes. BMJ Open Ophthalmol. 2018;3:e000133. 19. Durrie DS, Aâiâ AA. Lift-flap retreatment after laser in situ keratomileusis. J Refract Surg. 1999;15:150–153. 20. Walker MB, Wilson SE. Incidence and prevention of epithelial growth within the interface after laser in situ keratomileusis. Cornea. 2000;19:170–173. 21. Chan CCK, Boxer Wachler BS. Comparison of the effects of LASIK retreatment techniques on epithelial ingrowth rates. Ophthalmology. 2007;114:640–642. 编者≢：Dr 0ai 和Dr 0Xrri 是住医 㴠，Dr 3eWWey 是㱴他㺿，㫺⨘⒯，㱴他 大学，⹊眼科中心，住㴠项ㅅ主任。 手术医生▌在差异（例如经验或 手术水平），我们都认为这个 不太可能。讨论⭤⍢提出了一个 作者没有提及的㑳点，即AlFon 和研究作者可能▌在的经济利㯐 关系。 考虑到年㎡是再调位的一个 危险因素，我们讨论组成㴗⭯设 可能手术医生对于将年㎡患者带 回手术室的䡘值较低，因为一⊑ 而㬀他们是比较健康的群体，能 够Ⓒ受⿳㾍和再手术。 最后，未来的方㦢，考虑到 在研究结束时，研究的TEC1IS 晶状体已经有了再设计，我们 现在对于将来开展新改⼈的 TEC1IS II 晶状体和AFrySoI 晶 状体的比较研究特别感兴趣。新 型TEC1IS 散光晶状体设计能够 提高㩫㽊㢺定性解决此╌提到的 每个问题。 ᤕỻ 正确的散光轴定位对于㺔入散 光IOL 患者的视力结果是至关重 要的。利用IRIS 注册的真实世 界数据比较了单焦点散光IOL 的 手术再调位率，明确了⭞㠭有 关TEC1IS 单焦点散光IOL 的再 调位率高于AFrySoI 单焦点散光 IOL 的⌔☤。EWAP 参考文㦇 1. Anderson DF, et al. Global prevalence and economic and humanistic burden of astigmatism in cataract patients: a systematic literature review. Clin Ophthalmol. 2018;12:439–452. 2. Kessel L, et al. Toric intraocular lenses in the correction of astigmatism during cataract surgery: a systematic review and meta-analysis. Ophthalmology. 2016;123:275–286. 3. Visser N, et al. Toric intraocular lenses: historical overview, patient selection, IOL calculation, surgical techniques, clinical outcomes, and complications. J Cataract Refract Surg. 2013;39:624–637. 4. Dang S, et al. Estimating patient demand for ophthalmologists in the United States using Google Trends. Invest Ophthalmol Vis Sci. 2021;62:1724. 5. Oshika T, et al. Comparison of incidence of repositioning surgery to correct misalignment with three toric intraocular lenses. Eur J Ophthalmol. 2020;30:680–684. 6. Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125:1325–1331. 编者≢：Dr SXn 是住㴠医项ㅅ主任，Dr KoeniJ 是㴢㺿，㴢㗊，Weill Cornell 0ediFine 住㴠医。 上文接第39㮝
RkJQdWJsaXNoZXIy Njk2NTg0